Immune Checkpoint Inhibitors in Urology

Journal of the Association of Southern Urologists. 2026 Open access

Read full text
Authors: R. Vishnu Prakash, A V Venugopalan, Subeesh Parol, Shanmugha Das K.V, T. C. Farzana
DOI: 10.4103/jasu.jasu_22_25
Cited by: 0
References: 42

Abstract

Abstract Immune checkpoint inhibitors (ICIs) represent the next leap in the management of urological malignancies. In urology, ICIs are already used extensively in renal cell carcinoma and to extent in bladder carcinoma and prostate carcinoma. In this review article, we will be looking into ICIs’ use in various urological malignancies, the latest trials, and protocols.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Bladder and Urothelial Cancer Treatments Renal cell carcinoma treatment

Publication details

Journal / source
Journal of the Association of Southern Urologists.
Volume
3
Issue
1
Pages
9–17
Publication date
1 January 2026
Language
EN